Kamada (KMDA) EBT (QoQ) (2013 - 2026)
Kamada (KMDA) EBT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Kamada | 461.75 Mn | 432.27 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158.74% |
| Mar 31, 2026 | 13.88% |
| Dec 31, 2025 | -25.65% |
| Sep 30, 2025 | 79,977.98% |
| Jun 30, 2025 | -99.88% |
| Mar 31, 2025 | 168.93% |
| Dec 31, 2024 | -37.70% |
| Sep 30, 2024 | 87,826.04% |
| Jun 30, 2024 | -99.82% |
| Mar 31, 2024 | -51.45% |
| Dec 31, 2023 | 52.43% |
| Sep 30, 2023 | 73.02% |
| Jun 30, 2023 | 106,169.04% |
| Mar 31, 2023 | -100.06% |
| Dec 31, 2022 | 532,522.95% |
| Sep 30, 2022 | -99.98% |
| Jun 30, 2022 | 111.50% |
| Mar 31, 2022 | 138.80% |
| Dec 31, 2021 | -655.18% |
| Sep 30, 2021 | -10.05% |